Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02207647 · ClinicalTrials.gov registry record
Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients
A clinical trial, sponsored by Olive View-UCLA Education & Research Institute.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT02207647 is a clinical trial that was terminated before completion, run by Olive View-UCLA Education & Research Institute. The registered enrollment target is 1,000 participants.
The verdict
NCT02207647 was terminated before completion, sponsored by Olive View-UCLA Education & Research Institute.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Of all emergency room patients, persons presenting with encephalitis/meningitis syndrome of a potentially infectious nature are among those of greatest concern. Routine clinical and laboratory evaluation of such patients involves screening for known infectious disease agents, selection of which is nonstandardized. Progress in diagnostic technologies, especially molecular techniques based on genetic characteristics of potential pathogens, has greatly expanded the investigators capacity to evaluate specimens from patients for a much wider range of potential pathogens (bacterial, viral, fungal and parasitic agents). Use of Polymerase Chain Reaction (PCR) technology offers the possibility of identifying causative agents for the approximately 50% of all such presentations which go un-diagnosed. The investigators propose a study involving a collaboration between the EMERGEncy ID NET, a network of 10 geographically diverse university-affiliated urban emergency departments (coordinated by Olive View-UCLA Medical Center) and the Centers for Disease Control and Prevention (CDC), to use these new technologies to address this issue.
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02207647
The ClinicalTrials.gov registry entry for NCT02207647 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Olive View-UCLA Education & Research Institute, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT02207647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02207647 about?
NCT02207647 is a clinical study titled "Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients". Of all emergency room patients, persons presenting with encephalitis/meningitis syndrome of a potentially infectious nature are among those of greatest concern. Routine clinical and laboratory evaluation of such patients involves screening for known infectious disease agents, selection of which is n...
What is the current status of trial NCT02207647?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2014-04. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02207647?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT02207647?
This trial is sponsored by Olive View-UCLA Education & Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.